ARK Genomic Revolution ETF
Management Expense Ratio
0.22%
Annual fee
Dividend Yield
0%
Trailing 12-month
Distribution Frequency
Quarterly
Payout schedule
Assets Under Management
$1.2B
Total fund size
Investment Objective
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
Still holding bank mutual funds?
The average Canadian bank mutual fund charges a 2.2% MER— that's over 20x more than ARKG's fee. Switch to commission-free, self-directed investing and keep more of your returns. Open an account in minutes.
Affiliate disclosure: We may earn a commission at no cost to you.